Press Releases
-
SK bioscience will accelerate to apply for emergency use listing (EUL) to the World Health Organiz...2022.08.01
-
If approved, SK bioscience will accelerate to apply for emergency use listing (EUL) to the World Hea...2022.07.29
-
SK bioscience and Novavax agreement also includes production of the Novavax COVID-19 vaccine in pre...2022.07.19
-
Neutralizing antibody titres against Omicron variant BA.1 after a booster dose of SKYCovione™ were ...2022.07.13
-
SKYCovione™ will be ready to enter into domestic vaccine markets after passing the national lot rel...2022.06.29
-
· SK bioscience held the Global Forum to discuss about the Next Pandemic response strategy throug...2022.06.28
-
Trevor Mundel, President of the Global Health Division of the Bill & Melinda Gates Foundation(c...2022.05.17
-
Recombinant protein-based ‘GBP510’ with GSK pandemic adjuvant demonstrates superior neutralising tit...2022.04.29
-
For 4,037 adults over 18 years of age, GBP510(AS03) proves non-inferiority to an authorized COVID-19...2022.04.25
-
SK began developing an innovative technology to prevent viral infections and relieve symptoms throug...2022.04.13
-
SK submitted a post-approval change application for Nuvaxovid™, Novavax’ recombinant protein-based C...2022. 04. 07
-
Efficacy similar to adults 18 years and older with robust cross-reactive immune responses against Om...2022.03.23